| 1 |
32702725 | Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride. | 2020 Jul 15 |
2 |
| 2 |
33110062 | Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride. | 2020 Oct 27 |
2 |
| 3 |
30353958 | A 5α-reductase (SRD5A2) polymorphism is associated with serum testosterone and sex hormone-binding globulin in men, while aromatase (CYP19A1) polymorphisms are associated with oestradiol and luteinizing hormone reciprocally. | 2019 Feb |
1 |
| 4 |
30616540 | Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer. | 2019 Jan 7 |
1 |
| 5 |
30703436 | In silico and functional studies reveal novel loss-of-function variants of SRD5A2, but no variants explaining excess 5α-reductase activity. | 2019 Jun |
1 |
| 6 |
31272082 | Altered methylation pattern of the SRD5A2 gene in the cerebrospinal fluid of post-finasteride patients: a pilot study. | 2019 Aug 1 |
1 |
| 7 |
31601057 | In silico screening of potential lead compounds against 3-oxo-5-alpha-steroid 4-dehydrogenase 2 for treating prostate cancer. | 2019 Oct 5 |
1 |
| 8 |
32894851 | Spectrum of Pathogenic Variants in SRD5A2 in Indian Children with 46,XY Disorders of Sex Development and Clinically Suspected Steroid 5α-Reductase 2 Deficiency. | 2019 |
3 |
| 9 |
29610568 | Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population. | 2018 Feb |
2 |
| 10 |
27848231 | Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population. | 2017 Apr |
2 |
| 11 |
28323036 | Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer. | 2017 Jul 1 |
1 |
| 12 |
28324044 | Inverse Regulation of DHT Synthesis Enzymes 5α-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer. | 2017 Apr 1 |
1 |
| 13 |
28685147 | Genotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate Cancer. | 2017 |
2 |
| 14 |
26857022 | The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism. | 2016 Jun |
4 |
| 15 |
25598933 | The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population. | 2015 Jan |
2 |
| 16 |
25735326 | SRD5A2 gene polymorphisms and the risk of benign prostatic hyperplasia but not prostate cancer. | 2015 |
1 |
| 17 |
24793988 | Steroidogenesis of the testis -- new genes and pathways. | 2014 May |
2 |
| 18 |
24898559 | Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride. | 2014 Nov |
1 |
| 19 |
25310105 | Polymorphism of the SRD5A2 gene and the risk of prostate cancer. | 2014 Dec |
1 |
| 20 |
25336703 | Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones. | 2014 Dec |
2 |
| 21 |
23505265 | Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms. | 2013 Apr |
3 |
| 22 |
22707254 | Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts. | 2012 Dec |
2 |
| 23 |
20349245 | Practical approach to steroid 5alpha-reductase type 2 deficiency. | 2011 Jan |
1 |
| 24 |
21177315 | Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer. | 2011 May |
1 |
| 25 |
21511288 | Hypospadias risk and polymorphism in SRD5A2 and CYP17 genes: case-control study among Indian children. | 2011 Jun |
1 |
| 26 |
20151762 | Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride. | 2010 Jan |
1 |
| 27 |
20823678 | Establishment of a novel model for studying the effects of extracts of Chinese herb medicine on human type II 5alpha-reductase in vitro. | 2010 Sep |
1 |
| 28 |
19443907 | Longer (TA)n repeat but not A49T and V89L polymorphisms in SRD5A2 gene may confer prostate cancer risk in South Indian men. | 2009 Nov-Dec |
1 |
| 29 |
19492581 | Genetic analysis of the SRD5A2 gene in Indian patients with 5alpha-reductase deficiency. | 2009 Mar |
1 |
| 30 |
18469342 | No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned. | 2008 Aug 15 |
1 |
| 31 |
18483391 | VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. | 2008 May 15 |
1 |
| 32 |
19169095 | Finasteride-induced myalgia and HyperCKemia. | 2008 Dec |
1 |
| 33 |
17646096 | Establishment of type II 5alpha-reductase over-expressing cell line as an inhibitor screening model. | 2007 Nov-Dec |
2 |
| 34 |
15811930 | Combined inhibition of types I and II 5 alpha-reductase selectively augments the basal (nonpulsatile) mode of testosterone secretion in young men. | 2005 Jul |
1 |
| 35 |
16155734 | Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1. | 2005 |
1 |
| 36 |
16181229 | SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. | 2005 Oct |
1 |
| 37 |
14560315 | Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2. | 2004 Apr |
1 |
| 38 |
14991867 | Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. | 2004 Apr 1 |
1 |
| 39 |
15064320 | Compound heterozygous mutations in the SRD5A2 gene exon 4 in a male pseudohermaphrodite patient of Chinese origin. | 2004 May-Jun |
1 |
| 40 |
15194142 | Role of TGF-beta2 in the human hair cycle. | 2004 Jun |
1 |
| 41 |
15326487 | Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue. | 2004 Sep 23 |
1 |
| 42 |
12712437 | Polymorphic markers in the 5alpha-reductase type II gene and the incidence of prostate cancer. | 2003 Jul 1 |
1 |
| 43 |
12746845 | Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer. | 2003 Jun 15 |
1 |
| 44 |
12815006 | Association between two polymorphisms in the SRD5A2 gene and serum androgen concentrations in British men. | 2003 Jun |
1 |
| 45 |
12843198 | Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. | 2003 Jul |
1 |
| 46 |
12949937 | Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. | 2003 Oct 1 |
2 |
| 47 |
12042668 | 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer. | 2002 Jun |
1 |
| 48 |
12111704 | Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. | 2002 Jul 1 |
1 |
| 49 |
11340572 | Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population. | 2001 Jun 1 |
1 |
| 50 |
11355945 | A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland. | 2001 May 18 |
1 |